We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Countdown to DexCom (DXCM) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
Read MoreHide Full Article
In its upcoming report, DexCom (DXCM - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $0.50 per share, reflecting no change compared to the same period last year. Revenues are forecasted to be $1.1 billion, representing a year-over-year increase of 6.5%.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
Bearing this in mind, let's now explore the average estimates of specific DexCom metrics that are commonly monitored and projected by Wall Street analysts.
The combined assessment of analysts suggests that 'Revenue- Hardware' will likely reach $46.83 million. The estimate suggests a change of -46.5% year over year.
The average prediction of analysts places 'Revenue- Sensor and other' at $1.05 billion. The estimate indicates a year-over-year change of +11.3%.
According to the collective judgment of analysts, 'Revenue- United States' should come in at $796.17 million. The estimate indicates a year-over-year change of +3.5%.
The collective assessment of analysts points to an estimated 'Revenue- International' of $307.46 million. The estimate points to a change of +15.9% from the year-ago quarter.
Over the past month, DexCom shares have recorded returns of +13.3% versus the Zacks S&P 500 composite's +2.1% change. Based on its Zacks Rank #3 (Hold), DXCM will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Countdown to DexCom (DXCM) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
In its upcoming report, DexCom (DXCM - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $0.50 per share, reflecting no change compared to the same period last year. Revenues are forecasted to be $1.1 billion, representing a year-over-year increase of 6.5%.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
Bearing this in mind, let's now explore the average estimates of specific DexCom metrics that are commonly monitored and projected by Wall Street analysts.
The combined assessment of analysts suggests that 'Revenue- Hardware' will likely reach $46.83 million. The estimate suggests a change of -46.5% year over year.
The average prediction of analysts places 'Revenue- Sensor and other' at $1.05 billion. The estimate indicates a year-over-year change of +11.3%.
According to the collective judgment of analysts, 'Revenue- United States' should come in at $796.17 million. The estimate indicates a year-over-year change of +3.5%.
The collective assessment of analysts points to an estimated 'Revenue- International' of $307.46 million. The estimate points to a change of +15.9% from the year-ago quarter.
View all Key Company Metrics for DexCom here>>>
Over the past month, DexCom shares have recorded returns of +13.3% versus the Zacks S&P 500 composite's +2.1% change. Based on its Zacks Rank #3 (Hold), DXCM will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>